adverse event: SOC (Number of HGLTs included in SOC) | adverse event: HGLT |
---|---|
Psychiatric disorders (13) | Deliria (include confusion) |
Sleep disturbances | |
Psychiatric and behavioural symptoms NEC | |
Impulse control disorders NEC | |
Dementia and amnestic conditions | |
Suicidal and self-injurious behaviours NEC | |
Psychiatric disorders NEC | |
Personality disorders and disturbances in behavior | |
Changes in physical activity | |
Manic and bipolar mood disorders and disturbances | |
Anxiety disorders and symptoms | |
Disturbances in thinking and perception | |
Depressed mood disorders and disturbances | |
Nervous system disorders (5) | Sleep disturbances (include subtypes) |
Mental impairment disorders | |
Neurological disorders NEC | |
Neurological disorders of the eye | |
Movement disorders (include parkinsonism) | |
Movement disorders (include parkinsonism) | Product use issues |
Injuries by physical agents | |
Injuries NEC | |
Eye disorders (3) | Glaucoma and ocular hypertension |
Vision disorders | |
Ocular infections irritations and inflammations | |
Investigations (2) | Neurological special senses and psychiatric investigations |
Enzyme investigations NEC | |
Respiratory thoracic and mediastinal disorders (1) | Respiratory disorders NEC |
General disorders and administration site conditions (1) | Therapeutic and nontherapeutic effects (exclude toxicity) |